- Home
- SCNX vs NAII Comparison
SCNX vs NAII Comparison
Compare SCNX & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNX
- NAII
- Stock Information
- Founded
- SCNX 2010
- NAII 1980
- Country
- SCNX United States
- NAII United States
- Employees
- SCNX N/A
- NAII N/A
- Industry
- SCNX Other Pharmaceuticals
- NAII Medicinal Chemicals and Botanical Products
- Sector
- SCNX Health Care
- NAII Health Care
- Exchange
- SCNX Nasdaq
- NAII Nasdaq
- Market Cap
- SCNX 21.2M
- NAII 21.2M
- IPO Year
- SCNX 2020
- NAII 1987
- Fundamental
- Price
- SCNX $0.94
- NAII $3.50
- Analyst Decision
- SCNX
- NAII
- Analyst Count
- SCNX 0
- NAII 0
- Target Price
- SCNX N/A
- NAII N/A
- AVG Volume (30 Days)
- SCNX 298.5K
- NAII 6.0K
- Earning Date
- SCNX 11-05-2025
- NAII 11-12-2025
- Dividend Yield
- SCNX N/A
- NAII N/A
- EPS Growth
- SCNX N/A
- NAII N/A
- EPS
- SCNX N/A
- NAII N/A
- Revenue
- SCNX $128,202.00
- NAII $125,483,000.00
- Revenue This Year
- SCNX N/A
- NAII N/A
- Revenue Next Year
- SCNX N/A
- NAII N/A
- P/E Ratio
- SCNX N/A
- NAII N/A
- Revenue Growth
- SCNX N/A
- NAII 4.39
- 52 Week Low
- SCNX $0.69
- NAII $2.57
- 52 Week High
- SCNX $9.55
- NAII $6.77
- Technical
- Relative Strength Index (RSI)
- SCNX 33.59
- NAII 45.26
- Support Level
- SCNX $0.83
- NAII $3.28
- Resistance Level
- SCNX $0.91
- NAII $3.87
- Average True Range (ATR)
- SCNX 0.06
- NAII 0.17
- MACD
- SCNX 0.01
- NAII -0.04
- Stochastic Oscillator
- SCNX 43.05
- NAII 31.88
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.